vs
Kennedy-Wilson Holdings, Inc.（KW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Kennedy-Wilson Holdings, Inc.的1.6倍（$197.9M vs $120.6M），Kennedy-Wilson Holdings, Inc.净利率更高（48.1% vs 6.7%，领先41.4%），REPLIGEN CORP同比增速更快（13.6% vs -11.0%），REPLIGEN CORP自由现金流更多（$17.6M vs $-55.2M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -6.0%）
肯尼迪-威尔逊控股是一家房地产投资企业，公司总部位于美国加利福尼亚州比弗利山庄，业务覆盖全球多地房地产领域的投资与运营相关业务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
KW vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$120.6M
营收增速更快
RGEN
高出24.6%
-11.0%
净利率更高
KW
高出41.4%
6.7%
自由现金流更多
RGEN
多$72.8M
$-55.2M
两年增速更快
RGEN
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.6M | $197.9M |
| 净利润 | $58.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 57.3% | 9.0% |
| 净利率 | 48.1% | 6.7% |
| 营收同比 | -11.0% | 13.6% |
| 净利润同比 | 32.7% | 143.9% |
| 每股收益（稀释后） | $0.22 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KWRGEN
| Q4 25 | $120.6M | $197.9M | ||
| Q3 25 | $116.4M | $188.8M | ||
| Q2 25 | $135.7M | $182.4M | ||
| Q1 25 | $128.3M | $169.2M | ||
| Q4 24 | $135.5M | $174.1M | ||
| Q3 24 | $127.5M | $154.9M | ||
| Q2 24 | $132.0M | $154.1M | ||
| Q1 24 | $136.4M | $151.3M |
净利润KWRGEN
| Q4 25 | $58.0M | $13.3M | ||
| Q3 25 | $-10.2M | $14.9M | ||
| Q2 25 | $5.6M | $14.9M | ||
| Q1 25 | $-29.6M | $5.8M | ||
| Q4 24 | $43.7M | $-30.3M | ||
| Q3 24 | $-66.8M | $-654.0K | ||
| Q2 24 | $-48.3M | $3.3M | ||
| Q1 24 | $37.7M | $2.1M |
毛利率KWRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率KWRGEN
| Q4 25 | 57.3% | 9.0% | ||
| Q3 25 | -6.2% | 8.9% | ||
| Q2 25 | 7.4% | 7.6% | ||
| Q1 25 | -26.9% | 3.9% | ||
| Q4 24 | 36.7% | -17.7% | ||
| Q3 24 | -60.8% | -5.1% | ||
| Q2 24 | -45.5% | 1.0% | ||
| Q1 24 | 47.2% | 1.3% |
净利率KWRGEN
| Q4 25 | 48.1% | 6.7% | ||
| Q3 25 | -8.8% | 7.9% | ||
| Q2 25 | 4.1% | 8.2% | ||
| Q1 25 | -23.1% | 3.4% | ||
| Q4 24 | 32.3% | -17.4% | ||
| Q3 24 | -52.4% | -0.4% | ||
| Q2 24 | -36.6% | 2.2% | ||
| Q1 24 | 27.6% | 1.4% |
每股收益（稀释后）KWRGEN
| Q4 25 | $0.22 | $0.24 | ||
| Q3 25 | $-0.15 | $0.26 | ||
| Q2 25 | $-0.05 | $0.26 | ||
| Q1 25 | $-0.30 | $0.10 | ||
| Q4 24 | $0.24 | $-0.55 | ||
| Q3 24 | $-0.56 | $-0.01 | ||
| Q2 24 | $-0.43 | $0.06 | ||
| Q1 24 | $0.19 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $6.6B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资KWRGEN
| Q4 25 | $184.5M | $767.6M | ||
| Q3 25 | $382.6M | $748.7M | ||
| Q2 25 | $309.1M | $708.9M | ||
| Q1 25 | $356.6M | $697.2M | ||
| Q4 24 | $217.5M | $757.4M | ||
| Q3 24 | $367.1M | $784.0M | ||
| Q2 24 | $366.5M | $809.1M | ||
| Q1 24 | $541.9M | $780.6M |
总债务KWRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KWRGEN
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.6B | $2.1B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.7B | $2.0B | ||
| Q1 24 | $1.7B | $2.0B |
总资产KWRGEN
| Q4 25 | $6.6B | $2.9B | ||
| Q3 25 | $6.7B | $2.9B | ||
| Q2 25 | $6.8B | $2.9B | ||
| Q1 25 | $7.2B | $2.9B | ||
| Q4 24 | $7.0B | $2.8B | ||
| Q3 24 | $7.4B | $2.8B | ||
| Q2 24 | $7.5B | $2.9B | ||
| Q1 24 | $7.7B | $2.8B |
负债/权益比KWRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-55.2M | $17.6M |
| 自由现金流率自由现金流/营收 | -45.8% | 8.9% |
| 资本支出强度资本支出/营收 | 55.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.20× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-103.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流KWRGEN
| Q4 25 | $11.4M | $25.7M | ||
| Q3 25 | $-7.6M | $48.1M | ||
| Q2 25 | $42.0M | $28.6M | ||
| Q1 25 | $-51.9M | $15.0M | ||
| Q4 24 | $55.1M | $39.2M | ||
| Q3 24 | $-5.6M | $49.3M | ||
| Q2 24 | $36.7M | $42.2M | ||
| Q1 24 | $-5.6M | $44.7M |
自由现金流KWRGEN
| Q4 25 | $-55.2M | $17.6M | ||
| Q3 25 | $-18.0M | $43.4M | ||
| Q2 25 | $29.4M | $21.5M | ||
| Q1 25 | $-59.7M | $11.4M | ||
| Q4 24 | $-76.5M | $33.6M | ||
| Q3 24 | $-27.7M | $42.3M | ||
| Q2 24 | $-500.0K | $37.4M | ||
| Q1 24 | $-57.1M | $36.4M |
自由现金流率KWRGEN
| Q4 25 | -45.8% | 8.9% | ||
| Q3 25 | -15.5% | 23.0% | ||
| Q2 25 | 21.7% | 11.8% | ||
| Q1 25 | -46.5% | 6.8% | ||
| Q4 24 | -56.5% | 19.3% | ||
| Q3 24 | -21.7% | 27.3% | ||
| Q2 24 | -0.4% | 24.3% | ||
| Q1 24 | -41.9% | 24.0% |
资本支出强度KWRGEN
| Q4 25 | 55.2% | 4.1% | ||
| Q3 25 | 8.9% | 2.5% | ||
| Q2 25 | 9.3% | 3.9% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | 97.1% | 3.2% | ||
| Q3 24 | 17.3% | 4.5% | ||
| Q2 24 | 28.2% | 3.1% | ||
| Q1 24 | 37.8% | 5.5% |
现金转化率KWRGEN
| Q4 25 | 0.20× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 7.50× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | -0.15× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
RGEN
暂无分部数据
